Bridgefront Capital, LLC Novavax Inc Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $93,676 - $264,747	10,573 New	10,573 $108,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $97,831 - $200,488	-1,403 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $188,787 - $305,811	1,403 New	1,403 $201,000
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $251,053 - $382,058	-1,412 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $170,852 - $363,830	1,412 New	1,412 $300,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.